These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 18463398)

  • 1. Statins, breast cancer, and an invisible switch?
    Byers T
    Cancer Epidemiol Biomarkers Prev; 2008 May; 17(5):1026-7. PubMed ID: 18463398
    [No Abstract]   [Full Text] [Related]  

  • 2. Estrogen receptor-negative breast cancer is less likely to arise among lipophilic statin users.
    Kumar AS; Benz CC; Shim V; Minami CA; Moore DH; Esserman LJ
    Cancer Epidemiol Biomarkers Prev; 2008 May; 17(5):1028-33. PubMed ID: 18463402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prognostic value of hormonal receptors].
    Paradiso A; De Lena M
    Pathologica; 1987; 79(1059-1060):165-76. PubMed ID: 3327042
    [No Abstract]   [Full Text] [Related]  

  • 4. Progestin action and progesterone receptors in breast cancer.
    Chamness GC
    Cancer Res; 1989 Dec; 49(24 Pt 1):7176-9. PubMed ID: 2582458
    [No Abstract]   [Full Text] [Related]  

  • 5. Post-diagnosis statin use and breast recurrence sites in early stage breast cancer survivors.
    Harputluoglu H; Dizdar O; Karaahmet F; Altundag K
    Breast Cancer Res Treat; 2008 Aug; 110(3):541. PubMed ID: 17851754
    [No Abstract]   [Full Text] [Related]  

  • 6. [Endocrine therapy of breast cancer].
    Bassalyk LS; Murav'eva NI; Smirnova KD; Kuz'mina ZV
    Sov Med; 1981; (12):54-9. PubMed ID: 7038903
    [No Abstract]   [Full Text] [Related]  

  • 7. Time for reappraisal of progesterone-receptor testing in breast cancer management.
    MacGrogan G; de Mascarel I; Sierankowski G; Mauriac L; Debled M; Durand M; De Lara CT; Avril A; Picot V; Mathoulin-Pélissier S
    J Clin Oncol; 2005 Apr; 23(12):2870-1; author reply 2871. PubMed ID: 15838009
    [No Abstract]   [Full Text] [Related]  

  • 8. A call for clinical trials: lipophilic statins may prove effective in treatment and prevention of particular breast cancer subtypes.
    Kumar AS; Campbell M; Benz CC; Esserman LJ
    J Clin Oncol; 2006 May; 24(13):2127; author reply 2127-8. PubMed ID: 16648516
    [No Abstract]   [Full Text] [Related]  

  • 9. Estrogen receptors in early breast cancer.
    Cooke T; George D; Schields R; Maynard PV; Griffiths K
    Eur J Cancer (1965); 1980; Suppl 1():53-7. PubMed ID: 7318869
    [No Abstract]   [Full Text] [Related]  

  • 10. Cancer is heterogeneous.
    Guinebretiere JM
    J Clin Oncol; 2009 Jun; 27(16):2732; author reply 2734-5. PubMed ID: 19380436
    [No Abstract]   [Full Text] [Related]  

  • 11. Is immunohistochemistry less sensitive than quantitative reverse transcriptase polymerase chain reaction for hormone receptor status determination in breast cancer?
    Arnould L; Coudert B; Fumoleau P
    J Clin Oncol; 2009 Jun; 27(16):2733; author reply 2734-5. PubMed ID: 19380432
    [No Abstract]   [Full Text] [Related]  

  • 12. Triple negative breast cancer: clinicopathological characteristics and treatment strategies.
    Akiyama F; Iwase H
    Breast Cancer; 2009; 16(4):252-3. PubMed ID: 19506994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bisphosphonates: beyond prevention of bone metastases.
    Rennert G
    J Natl Cancer Inst; 2011 Dec; 103(23):1728-9. PubMed ID: 22021669
    [No Abstract]   [Full Text] [Related]  

  • 14. [Occult multicentric breast cancer].
    Vtorushin SV; Zab'ialova MV; Glushchenko SA; Perel'muter VM; Slonimskaia EM
    Vopr Onkol; 2009; 55(1):38-41. PubMed ID: 19435197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic impact of tumour-specific HMG-CoA reductase expression in primary breast cancer.
    Borgquist S; Jögi A; Pontén F; Rydén L; Brennan DJ; Jirström K
    Breast Cancer Res; 2008; 10(5):R79. PubMed ID: 18808688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statins: health-promoting agents show promise for breast cancer prevention.
    Kumar AS; Esserman LJ
    Clin Breast Cancer; 2005 Dec; 6(5):455-9. PubMed ID: 16381630
    [No Abstract]   [Full Text] [Related]  

  • 17. Breast cancer molecular subtypes in patients with locally advanced disease: impact on prognosis, patterns of recurrence, and response to therapy.
    Huber KE; Carey LA; Wazer DE
    Semin Radiat Oncol; 2009 Oct; 19(4):204-10. PubMed ID: 19732684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of a gene expression profile on breast cancer decisions.
    Henry LR; Stojadinovic A; Swain SM; Prindiville S; Cordes R; Soballe PW
    J Surg Oncol; 2009 May; 99(6):319-23. PubMed ID: 19204954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insights into the role of progesterone receptors in breast cancer.
    Fuqua SA; Cui Y; Lee AV; Osborne CK; Horwitz KB
    J Clin Oncol; 2005 Feb; 23(4):931-2; author reply 932-3. PubMed ID: 15681552
    [No Abstract]   [Full Text] [Related]  

  • 20. Statins in the prevention of prostate cancer recurrence: are certain biases exaggerating the results?
    Azoulay L; Suissa S
    J Clin Oncol; 2010 Nov; 28(31):e644; author reply e645-6. PubMed ID: 20876424
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.